1,047
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine

, , , &
Pages 889-894 | Received 31 May 2016, Accepted 23 Oct 2016, Published online: 21 Feb 2017

References

  • Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2013; 62:1-43.
  • Barr IG, Russell C, Besselaar TG, Cox NJ, Daniels RS, Donis R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, et al. WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine 2014; 32:4713-25; PMID:24582632; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2014.02.014
  • European Medicines Agency. Regulatory information - EU recommendations for 2015/2016 seasonal flu vaccine composition. London: EMA, 2015.
  • European Medicines Agency - Committee for Medicinal Products for Human Use. Explanatory note on the withdrawal of the Note for guidance on harmonisation of requirements for influenza vaccines and of the core SmPC/PL for inactivated seasonal influenza vaccines EMA/CHMP/VWP/40560/2014. London, 2014. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500161022.pdf
  • European Medicines Agency - Pharmacovigilance Risk Assessment Committee. Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU EMA/PRAC/222346/2014. London, 2014. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/04/WC500165492.pdf
  • Atmar RL, Patel SM, Keitel WA. Intanza®: a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines 2010; 9:1399-409; PMID:21105776; https://doi.org/http://dx.doi.org/10.1586/erv.10.134
  • Hoon Han S, Hee Woo J, Weber F, Joo Kim W, Ran Peck K, Il Kim S, Hwa Choi Y, Myung Kim J. Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial. Hum Vaccin Immunother 2013; 9:1971-7; PMID:23778938; https://doi.org/http://dx.doi.org/10.4161/hv.25295
  • Troy JD, Hill HR, Ewell MG, Frey SE. Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine. Vaccine 2015; 33:5425-31; PMID:26319063; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2015.08.032
  • Beyer WE, Palache AM, Kerstens R, Masurel N. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis 1996; 15:65-70; PMID:8641306; https://doi.org/http://dx.doi.org/10.1007/BF01586187